Hengrui Pharmaceuticals is said to weigh second listing in Hong Kong
JIANGSU Hengrui Pharmaceuticals is considering a second listing in Hong Kong that could happen as soon as next year, according ...
JIANGSU Hengrui Pharmaceuticals is considering a second listing in Hong Kong that could happen as soon as next year, according ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.